Market Cap (In USD)
8.48 Million
Revenue (In USD)
-
Net Income (In USD)
-79.03 Thousand
Avg. Volume
797.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0225-0.6748
- PE
- -
- EPS
- -
- Beta Value
- 0.0
- ISIN
- US63948Q1058
- CUSIP
- 63948Q105
- CIK
- 1329944
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. James B. Hovis
- Employee Count
- -
- Website
- https://www.ndtpharma.com
- Ipo Date
- 2008-01-22
- Details
- NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Vienna, Virginia.
More Stocks
-
9556INTLOOP Inc.
9556
-
AZNAstraZeneca PLC
AZN
-
229000Gencurix Inc.
229000
-
300664
-
8107
-
PURI
-
9514
-
DUELLDuell Oyj
DUELL